Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
22 hedge funds and large institutions have $6.62M invested in Aptose Biosciences, Inc. in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
12% more capital invested
Capital invested by funds: $5.91M → $6.62M (+$713K)
10% more funds holding
Funds holding: 20 → 22 (+2)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$199K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
+$171K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$125K |
| 4 |
Squarepoint
New York
|
+$57.9K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
+$42.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$231K |
| 2 |
AA
Antipodean Advisors
New York
|
-$48K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$21.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$12.7K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$905 | -1 | Closed |
|
APTO Hedge Fund Activity: Q1 2019 in Review
22 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2019, worth a combined $6.62M — up 12% from $5.91M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new APTO positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $199K. The largest seller was Morgan Stanley, cutting an estimated $231K.
- 22 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2019, up from 20 in Q4 2018.
- Funds reported $6.62M of Aptose Biosciences, Inc. stock for Q1 2019, up 12% quarter-over-quarter.
- 6 funds opened new Aptose Biosciences, Inc. positions in Q1 2019 and 4 closed out, a net change of +2 holders.
- The largest Aptose Biosciences, Inc. buyer in Q1 2019 was Virtu Financial, an estimated $199K added.
- The largest Aptose Biosciences, Inc. seller in Q1 2019 was Morgan Stanley, an estimated $231K sold.
Based on aggregated 13F filings for Q1 2019.